Tag Archives: BRCA2

QIAGEN Supports New ACMG Guidelines with Integration into Data Interpretation Tools

The American College of Medical Genetics and Genomics (ACMG), in collaboration with the Association for Molecular Pathology (AMP), recently published new guidelines for the interpretation of sequence variants. These guidelines are significant in their inclusion of an evidence-based gene variant … Read More

Posted in Events, News, Products | Tagged , , , , , , , Product ,

Clinical Lab Director’s View Part 3: Somatic and Hereditary Cancer

  Recently we’ve been looking at the challenges of interpreting and reporting variants found in genetic tests by clinical labs. In this final post in our miniseries, QIAGEN Bioinformatics’ Clinical Science Director Junaid Shabbeer walks us through the intricacies of … Read More

Posted in Events, Products | Tagged , , , , , , , Product